These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31199560)

  • 1. Identification of potential diagnostic biomarkers for Parkinson's disease.
    Jiang F; Wu Q; Sun S; Bi G; Guo L
    FEBS Open Bio; 2019 Aug; 9(8):1460-1468. PubMed ID: 31199560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
    Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
    Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
    Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
    BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease.
    Huang J; Li B; Wei H; Li C; Liu C; Mi H; Chen S
    Sci Rep; 2024 Jan; 14(1):2167. PubMed ID: 38272954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential blood biomarkers for Parkinson's disease by gene expression and DNA methylation data integration analysis.
    Wang C; Chen L; Yang Y; Zhang M; Wong G
    Clin Epigenetics; 2019 Feb; 11(1):24. PubMed ID: 30744671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Kong P; Lei P; Zhang S; Li D; Zhao J; Zhang B
    Neurosci Lett; 2018 Jan; 662():51-58. PubMed ID: 28965931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling predicts pathways and genes associated with Parkinson's disease.
    Liu S; Zhang Y; Bian H; Li X
    Neurol Sci; 2016 Jan; 37(1):73-79. PubMed ID: 26269422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging-related biomarkers for the diagnosis of Parkinson's disease based on bioinformatics analysis and machine learning.
    Yang W; Xu S; Zhou M; Chan P
    Aging (Albany NY); 2024 Sep; 16(17):12191-12208. PubMed ID: 39264583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-based gene-expression biomarkers identification for the non-invasive diagnosis of Parkinson's disease using two-layer hybrid feature selection.
    Augustine J; Jereesh AS
    Gene; 2022 May; 823():146366. PubMed ID: 35202733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diagnostic model for Parkinson's disease based on circadian rhythm-related genes.
    Wang L; Bao Y; Duan X; Li H; Ding H; Yu F; Yang J; Hu Y; Huang D
    J Transl Med; 2024 Jul; 22(1):635. PubMed ID: 38978048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease.
    Li T; Tang W; Zhang L
    Neurol Sci; 2016 Aug; 37(8):1327-33. PubMed ID: 27146810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Biomarkers for Early Diagnosis of Acute Myocardial Infarction.
    Ge WH; Lin Y; Li S; Zong X; Ge ZC
    J Cell Biochem; 2018 Jan; 119(1):650-658. PubMed ID: 28636181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease.
    Hossein-Nezhad A; Fatemi RP; Ahmad R; Peskind ER; Zabetian CP; Hu SC; Shi M; Wahlestedt C; Zhang J; Faghihi MA
    J Parkinsons Dis; 2016; 6(1):109-17. PubMed ID: 26889637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression Rate Associated Peripheral Blood Biomarkers of Parkinson's Disease.
    Fan Y; Xiao S
    J Mol Neurosci; 2018 Jul; 65(3):312-318. PubMed ID: 29936662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential genomic biomarkers for Parkinson's disease using data pooling of gene expression microarrays.
    Lin Z; Zhou L; Li Y; Liu S; Xie Q; Xu X; Wu J
    Biomark Med; 2021 Jun; 15(8):585-595. PubMed ID: 33988461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.